ARHGAP11B
Inactive Rho GTPase-activating protein 11B
Also known as: B'-T, FAM7B1, RHGBB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3KRB8
- Gene
- ARHGAP11B
- Ensembl
- ENSG00000285077
- Chromosome
- 15
- Canonical length
- 267 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable GTPase activator activity. Involved in cerebral cortex development and negative regulation of mitochondrial membrane permeability. Acts upstream of with a positive effect on glutamine catabolic process. Located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
267 residues, UniProt reviewed canonical sequence.
>Q3KRB8|ARHGAP11B
1 MWDQRLVKLA LLQHLRAFYG IKVKGVRGQC DRRRHETAAT EIGGKIFGVP FNALPHSAVP
61 EYGHIPSFLV DACTSLEEHI HTEGLFRKSG SVIRLKALKN KVDHGEGCLS SAPPCDIAGL
121 LKQFFRELPE PILPADLHEA LLKAQQLGTE EKNKAILLLS CLLADHTVHV LRYFFNFLRN
181 VSLRSSENKM DSSNLAVIFA PNLLQTSEGH EKMSSNAEKK GVYQTLSWKR YQPCWVLMVS
241 VLLHHWKALK KVNMKLLVNI REREDNVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARHGAP11B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 4.7 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 4.7 nTPM
- lymph node: 1.3 nTPM
- thymus: 1.3 nTPM
- appendix: 1.2 nTPM
- esophagus: 0.9 nTPM
- tonsil: 0.8 nTPM
Single-cell type
- enteric transient amplifying cells: 3.6 nCPM
- extravillous trophoblasts: 1.5 nCPM
- foveolar cells: 1.1 nCPM
- gastric chief cells: 1.1 nCPM
- enteric stem cells: 1 nCPM
- kupffer cells: 1 nCPM
Immune cell
- basophil: 0.9 nTPM
- naive B-cell: 0.5 nTPM
- memory CD4 T-cell: 0.4 nTPM
- plasmacytoid DC: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
Brain region
- choroid plexus: 1.6 nTPM
- medulla oblongata: 1.3 nTPM
- hypothalamus: 1.1 nTPM
- midbrain: 1.1 nTPM
- pons: 1.1 nTPM
- spinal cord: 1.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.56
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.35
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cerebral cortex development
- L-glutamine catabolic process
- negative regulation of mitochondrial membrane permeability
- regulation of small GTPase mediated signal transduction
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARHGAP11B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARHGAP11B as an antibody target. Whether an autoantibody or antibody against ARHGAP11B could matter depends on whether native ARHGAP11B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARHGAP11B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARHGAP11B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...